Stewart Cole – President, Institut Pasteur, France
Stewart Cole, president of Institut Pasteur, speaks out about his aspirations as the first foreign president of the institute and the main themes of the new strategic plan. Brexit…
Address: 37 rue Saint-Romain, 69008 Lyon,France
Tel: +33 (0)4 72 78 25 25
Web: http://www.merck.fr/fr/index.html;jsessionid=264C78DA1A1A6E632FADB2287B91481F
Merck France is compose of several divisions:
Merck Santé: Commercializes branded medicines developed by the group Merck’s own research at international level
Merck Serono: Commercializes the group’s branded prescription drug products in France.
Merck Serono Biodevelopment S.A.S.: Development of the production process, analytical and purification laboratories and Good Manufacturing Practice production and is at the frontier between research and manufacturing.
Théramex S.A.M.: Women’s health Products
Merck Medication Familiale: Home Healthcare Products
Merck Chimie S.A.S.: Sale & marketing organization, being part of the chemical branch of the Merck Group
Therapeutics
Oncology
Neurology
Fertility
Endocrinology
CardioMetabolic
Dermatology
Emergency products
Alcology
Gynecology
OTC
API
Stewart Cole, president of Institut Pasteur, speaks out about his aspirations as the first foreign president of the institute and the main themes of the new strategic plan. Brexit…
Since 1978, Alban Muller has been a point of reference for natural ingredients in cosmetics, pharma and nutraceuticals. In this interview, Mr. Muller, founder and CEO, explains the strategic role…
Catherine Bourrienne-Bautista, Déléguée générale of the GEMME (L’association Genérique Même Medicament, France’s generics and biosimilars association), provides her take on the state of the generics and biosimilars industry in France.…
Maurice-Pierre Planel, president of the CEPS (Comité économique des produits de santé), details how the French government is unique in the way that they engage in drug pricing and comments…
Oliver Brandicourt, Sanofi’s CEO has kept his promise to steer the company back on the path to growth. This change in fortune comes after the French Pharma giant suffered losses…
As the UK prepares to leave the European Union in March 2019, stakeholders across the European life sciences industry are busy preparing for Brexit’s potential impact on their operations. In…
Thierry Philip, president of Institut Curie, talks about the organization, the effect of cancer on Social Security and the need for a cohesive European plan involving all oncology research institutions…
Ipsen global CEO David Meek provides a fascinating look into the French pharmaceutical ecosystem, Ipsen’s bold global expansion plans, its R&D transformation, and the exciting changes to come. From our…
Dr. Catherine Jessus, Director of the INSB (Institute of Biological Sciences), the largest branch of the CNRS (National Center for Scientific Research) in France, discusses the strengths and weaknesses of…
Eric Bothorel, Deputy at the French Assemblée Nationale and responsible for the parliamentary group on data, knowledge & AI, provides an exclusive interview on France’s digitalization process. Bothorel describes France’s…
Dr. Julien Borowczyk, Secretary of the Social Affairs Commission at the French Assemblée Nationale, offers his insights on the upcoming changes to the French healthcare system. He walks our audience…
Genethon, a laboratory created by the patient organization AFM-Telethon, is one of the world’s leaders in the development of biotherapies for rare diseases. In this interview Genethon’s CEO Frédéric Revah…
See our Cookie Privacy Policy Here